Evaluation of the APTIMA Combo 2 Assay using self-administered vaginal swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae

Tania Crucitti; Bénédicte De Deken; Hilde Smet; Vicky Cuylaerts; Saïd Abdellati; Bea Vuylsteke

doi:10.1016/j.diagmicrobio.2013.03.011

Evaluation of the APTIMA Combo 2 Assay using self-administered vaginal swabs for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae

Diagn Microbiol Infect Dis. 2013 Jul;76(3):385-6. doi: 10.1016/j.diagmicrobio.2013.03.011. Epub 2013 Apr 15.

Authors

Tania Crucitti¹, Bénédicte De Deken, Hilde Smet, Vicky Cuylaerts, Saïd Abdellati, Bea Vuylsteke

Affiliation

¹ Institute of Tropical Medicine, Antwerp, Belgium. tcrucitti@tg.be

PMID: 23598167
DOI: 10.1016/j.diagmicrobio.2013.03.011

Abstract

We report on the performance of the APTIMA Combo 2 assay for the detection of chlamydial infection and gonorrhea using self-administered vaginal specimens in specimen transport medium and specimen kept dry. The results are compared with the results using the Amplicor assay and the BD ProbeTec assay™.

Publication types

Evaluation Study

MeSH terms

Chlamydia Infections / diagnosis*
Chlamydia Infections / epidemiology
Chlamydia Infections / microbiology
Chlamydia trachomatis / genetics*
Cross-Sectional Studies
Female
Gonorrhea / diagnosis*
Gonorrhea / epidemiology
Gonorrhea / microbiology
Humans
Molecular Diagnostic Techniques
Neisseria gonorrhoeae / genetics*
Prevalence
Reagent Kits, Diagnostic
Sensitivity and Specificity
Sex Workers
Specimen Handling
Vagina / microbiology

Substances

Reagent Kits, Diagnostic